Translocator protein — Drug Target

All drugs that target Translocator protein — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

alpidem · adinazolam

Marketed (1)

• Ananxyl · alpidem · Neuroscience

Phase 2 pipeline (1)

• Deracyn · adinazolam · Neuroscience
  Deracyn works by binding to the translocator protein, which is involved in regulating the activity of GABA, a neurotransmitter that helps calm the brain.